"The manufacturing facility in Suzhou will be capable of...

"The manufacturing facility in Suzhou will be capable of producing between 300,000 and 500,000 units of BCDs monthly during the first 6 months with production expanding to 5 million units per month"

And this was from 2010, just as a rough indicator of the future potential:

"⎯ Potential to deliver to Medigard up to USD 15c per device sold
⎯ Minimum 70 million units for the Blood Collection Device over the five‐year term of initial agreement.
⎯ US market consumes 700m Blood Collection Devices per year
⎯ Agreements could conservatively deliver revenues to Medigard across all products of up to $40m per
annum within 5 years"